Immuron (IMRN) Property, Plant & Equipment (Net) Growth (3y) (2019 - 2025)
Immuron (IMRN) Property, Plant & Equipment (Net) Growth (3y) (2019 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PP&E (Net) Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
-14.40% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
3.41% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
13.10% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Immuron |
1.05 Bn |
1.05 Bn |
- |
-80.67% |
| Date | Value |
|---|
| Sep 2, 2025 |
-80.67% |
| Jun 30, 2025 |
-23.41% |
| Dec 31, 2024 |
52.97% |
| Jun 30, 2024 |
57.61% |
| Dec 31, 2023 |
27.40% |
| Aug 30, 2023 |
-69.53% |
| Jun 30, 2023 |
42.34% |
| Dec 31, 2022 |
494.85% |
| Jun 30, 2022 |
138.27% |
| Dec 31, 2021 |
6.61% |
| Jun 30, 2021 |
18.97% |
| Dec 31, 2020 |
-66.39% |
| Sep 1, 2020 |
55.46% |
| Jun 30, 2020 |
48.55% |
| Dec 31, 2019 |
-62.68% |
